Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire Arrived EquityMultiple

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Top Smart Score Stocks

Plans & Pricing

Research Tools

Trending Stocks

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Economic Indicators

Economic Indicators Center

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Penny Stock Screener

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

Paradigm Biopharmaceuticals Ltd. (AU:PAR)

ASX:PAR

Australian Market

PAR

Paradigm Biopharmaceuticals Ltd.

Technical Analysis

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Paradigm Biopharmaceuticals Ltd. (PAR) Stock News & Sentiment

22 Followers

Paradigm Biopharmaceuticals Director Acquires New Options

Company Announcements

Paradigm Biopharmaceuticals Director Acquires New Options

8d ago

Paradigm Biopharmaceuticals Announces Director’s Securities Interest Update

Company Announcements

Paradigm Biopharmaceuticals Announces Director’s Securities Interest Update

8d ago

Paradigm Biopharmaceuticals Issues New Securities to Bolster Strategic Initiatives

Company Announcements

Paradigm Biopharmaceuticals Issues New Securities to Bolster Strategic Initiatives

12d ago

Paradigm Biopharmaceuticals Amends Bonus Issue Announcement

Company Announcements

Paradigm Biopharmaceuticals Amends Bonus Issue Announcement

20d ago

Paradigm Biopharmaceuticals Announces Strategic Bonus Issue of Securities

Company Announcements

Paradigm Biopharmaceuticals Announces Strategic Bonus Issue of Securities

22d ago

Paradigm Biopharmaceuticals Unveils Shareholder Reward Program with Potential $111M Fundraising

Company Announcements

Paradigm Biopharmaceuticals Unveils Shareholder Reward Program with Potential $111M Fundraising

22d ago

Paradigm Biopharmaceuticals Advances Phase 3 Trials with Strong Financial Backing

Company Announcements

Paradigm Biopharmaceuticals Advances Phase 3 Trials with Strong Financial Backing

23d ago

More AU:PAR News >

PAR News on the Web

2025-02-04

Health Check: Good golly Miss Molly! Emyria says Ecstasy works for PTSD, months after treatment

StockHead

Neutral

2025-02-03

Paradigm eyes $110m plus raise with shareholder loyalty offer

StockHead

Neutral

2025-02-03

Paradigm closer to phase III clinical trial with appointment of preferred CRO

StockHead

Neutral

2025-01-30

Paradigm Biopharmaceuticals Advances Phase 3 Trials with Strong Financial Backing

TipRanks News

Neutral

2025-01-29

Phase III Trials: It#8217;s crunch time for these ASX health stocks

StockHead

Neutral

2025-01-29

Paradigm Biopharmaceuticals Announces ASX Quotation of Securities

TipRanks News

Neutral

2025-01-24

ASX Lunch Wrap: ASX edges up on Wall Street#8217;s record high, as Trump’s oil push stirs markets

StockHead

Neutral

2025-01-23

Health Check: From feather duster to rooster, Nanosonics again rules the roost

StockHead

Neutral

News Score - Last 7 Days

Neutral

AU:PAR

Sector Average

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

This Week50%

Sector Average57%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AU:PAR’s Media Buzz Sentiment?

Currently, no data Available

What is AU:PAR’s weekly average amount of articles?

Currently, no data Available

What is AU:PAR’s News Sentiment?

50% of articles about AU:PAR were positive this week, compared to its sector average of 57%.

Healthcare Stocks that are Trending in the News

SHGSingular Health Group Ltd

RCUSArcus Biosciences

HCMHUTCHMED

PENPenumbra

AMNAMN Healthcare Services

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing